Perrigo (PRGO) Net Equity Issued and Repurchased (2013 - 2019)
Perrigo (PRGO) posted quarterly Net Equity Issued and Repurchased of $200000.0 for Q4 2019, down 33.33% year-over-year from $300000.0 in Q4 2018, and down 50.0% quarter-over-quarter from $400000.0 in Q3 2019.
Perrigo (PRGO) Net Equity Issued and Repurchased (2013 - 2019) Analysis & Trends
Perrigo (PRGO) has reported Net Equity Issued and Repurchased for 7 consecutive years, with $200000.0 the latest figure, recorded in Q4 2019.
- In Q4 2019, Net Equity Issued and Repurchased fell 33.33% year-over-year to $200000.0; the TTM figure through Dec 2020 stood at $600000.0 (down 68.42% YoY), while the FY2019 annual figure was $900000.0, down 30.77% from the prior year.
- Net Equity Issued and Repurchased slipped to $200000.0 in Q4 2019 per PRGO's latest filing, from $400000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $6.2 million in Q3 2015 and bottomed at -$1.1 million in Q4 2016.
- Historically, Net Equity Issued and Repurchased has averaged $1.3 million across 5 years, with a median of $350000.0 in 2017.
- Annual changes were most pronounced in 2018 — Net Equity Issued and Repurchased surged 233.33% — and 2019, when it plunged 60.0%.
- Perrigo's Net Equity Issued and Repurchased stood at $6.2 million in 2015, then tumbled by 117.74% to -$1.1 million in 2016, then surged by 118.18% to $200000.0 in 2017, then jumped by 50.0% to $300000.0 in 2018, then plunged by 33.33% to $200000.0 in 2019.
- Business Quant data shows PRGO's Net Equity Issued and Repurchased at $200000.0 in Q4 2019, $400000.0 in Q3 2019, and $300000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Perrigo | 1.91 Bn | 1.51 Bn | 313.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 200,000.00 |
| Dec 31, 2019 | 200,000.00 |
| Sep 28, 2019 | 400,000.00 |
| Sep 28, 2019 | 400,000.00 |
| Dec 31, 2018 | 300,000.00 |
| Dec 31, 2018 | 300,000.00 |
| Sep 29, 2018 | 1.00 Mn |
| Sep 29, 2018 | 1.00 Mn |
| Dec 31, 2017 | 200,000.00 |
| Dec 31, 2017 | 200,000.00 |
| Sep 30, 2017 | 300,000.00 |
| Sep 30, 2017 | 300,000.00 |
| Jul 1, 2017 | 200,000.00 |
| Jul 1, 2017 | 200,000.00 |
| Dec 31, 2016 | -1.10 Mn |
| Dec 31, 2016 | -1.10 Mn |
| Apr 2, 2016 | 3.10 Mn |
| Apr 2, 2016 | 3.10 Mn |
| Sep 26, 2015 | 6.20 Mn |
| Sep 26, 2015 | 6.20 Mn |